Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Prehypertensive African-American women have preserved nitric oxide and renal function but high cardiovascular risk.

Feairheller DL, Sturgeon KM, Diaz KM, Veerabhadrappa P, Williamson ST, Crabbe DL, Brown MD.

Kidney Blood Press Res. 2010;33(4):282-90. doi: 10.1159/000317944. Epub 2010 Jul 13.

2.

Roles of nitric oxide and oxidative stress in the regulation of blood pressure and renal function in prehypertensive Ren-2 transgenic rats.

Vanecková I, Kramer HJ, Novotná J, Kazdová L, Opocenský M, Bader M, Ganten D, Cervenka L.

Kidney Blood Press Res. 2005;28(2):117-26. Epub 2005 Mar 23.

3.

Plasma C-terminal pro-endothelin-1 is associated with target-organ damage in African Americans with hypertension.

Habib A, Al-Omari MA, Khaleghi M, Morgenthaler NG, Struck J, Bergmann A, Mosley TH, Turner ST, Kullo IJ.

Am J Hypertens. 2010 Nov;23(11):1204-8. doi: 10.1038/ajh.2010.149. Epub 2010 Jul 15.

4.

Nitric oxide activity in childhood hypertension.

Goonasekera CD, Shah V, Rees DD, Dillon MJ.

Arch Dis Child. 1997 Jul;77(1):11-6.

5.

The relation of C--reactive protein to chronic kidney disease in African Americans: the Jackson Heart Study.

Fox ER, Benjamin EJ, Sarpong DF, Nagarajarao H, Taylor JK, Steffes MW, Salahudeen AK, Flessner MF, Akylbekova EL, Fox CS, Garrison RJ, Taylor HA Jr.

BMC Nephrol. 2010 Jan 15;11:1. doi: 10.1186/1471-2369-11-1.

6.

Endothelial-dependent flow-mediated dilation in African Americans with masked-hypertension.

Veerabhadrappa P, Diaz KM, Feairheller DL, Sturgeon KM, Williamson ST, Crabbe DL, Kashem AM, Brown MD.

Am J Hypertens. 2011 Oct;24(10):1102-7. doi: 10.1038/ajh.2011.103. Epub 2011 Jun 16.

7.

Cardiovagal modulation, oxidative stress, and cardiovascular risk factors in prehypertensive subjects: cross-sectional study.

Thiyagarajan R, Pal P, Pal GK, Subramanian SK, Bobby Z, Das AK, Trakroo M.

Am J Hypertens. 2013 Jul;26(7):850-7. doi: 10.1093/ajh/hpt025. Epub 2013 Mar 6.

PMID:
23466463
8.

Association of urinary sodium/potassium ratio with blood pressure: sex and racial differences.

Hedayati SS, Minhajuddin AT, Ijaz A, Moe OW, Elsayed EF, Reilly RF, Huang CL.

Clin J Am Soc Nephrol. 2012 Feb;7(2):315-22. doi: 10.2215/CJN.02060311. Epub 2011 Nov 23.

9.

Long-term effects of kidney donation on renal function and blood pressure in African Americans.

Budisavljevic MN, Nietert PJ, Zhai Y, Dooley MJ, Rajagopalan PR.

Clin J Am Soc Nephrol. 2011 Jun;6(6):1474-80. doi: 10.2215/CJN.08240910. Epub 2011 May 5.

10.

Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate.

Lewis J, Agodoa L, Cheek D, Greene T, Middleton J, O'Connor D, Ojo A, Phillips R, Sika M, Wright J Jr; African-American Study of Hypertension and Kidney Disease.

Am J Kidney Dis. 2001 Oct;38(4):744-53. Erratum in: Am J Kidney Dis 2002 Feb;39(2):444.

PMID:
11576877
11.
12.

Contribution of circulating angiotensinogen concentrations to variations in aldosterone and blood pressure in a group of African ancestry depends on salt intake.

Michel FS, Norton GR, Majane OH, Badenhorst M, Vengethasamy L, Paiker J, Maseko MJ, Sareli P, Woodiwiss AJ.

Hypertension. 2012 Jan;59(1):62-9. doi: 10.1161/HYPERTENSIONAHA.111.181230. Epub 2011 Dec 5.

13.

Longitudinal changes in hematocrit in hypertensive chronic kidney disease: results from the African-American Study of Kidney Disease and Hypertension (AASK).

Chen TK, Estrella MM, Astor BC, Greene T, Wang X, Grams ME, Appel LJ.

Nephrol Dial Transplant. 2015 Aug;30(8):1329-35. doi: 10.1093/ndt/gfv037. Epub 2015 Mar 27.

14.

A comparison of iothalamate-GFR and serum creatinine-based outcomes: acceleration in the rate of GFR decline in the African American Study of Kidney Disease and Hypertension.

Lewis J, Greene T, Appel L, Contreras G, Douglas J, Lash J, Toto R, Van Lente F, Wang X, Wright JT Jr; AASK Study Group.

J Am Soc Nephrol. 2004 Dec;15(12):3175-83.

15.

Albuminuria and racial disparities in the risk for ESRD.

McClellan WM, Warnock DG, Judd S, Muntner P, Kewalramani R, Cushman M, McClure LA, Newsome BB, Howard G.

J Am Soc Nephrol. 2011 Sep;22(9):1721-8. doi: 10.1681/ASN.2010101085. Epub 2011 Aug 25.

16.

Effect of L-arginine infusion in normotensive subjects with and without a family history of hypertension.

Herlitz H, Jungersten LU, Wikstrand J, Widgren BR.

Kidney Int. 1999 Nov;56(5):1838-45.

17.

Relationship between GFR and albuminuria in stage 1 hypertension.

Palatini P, Mos L, Ballerini P, Mazzer A, Saladini F, Bortolazzi A, Cozzio S, Casiglia E; HARVEST Investigators.

Clin J Am Soc Nephrol. 2013 Jan;8(1):59-66. doi: 10.2215/CJN.03470412. Epub 2012 Sep 27.

18.

Creatinine clearance as a measure of GFR in screenees for the African-American Study of Kidney Disease and Hypertension pilot study.

Coresh J, Toto RD, Kirk KA, Whelton PK, Massry S, Jones C, Agodoa L, Van Lente F.

Am J Kidney Dis. 1998 Jul;32(1):32-42.

PMID:
9669421
19.

Supplemental Content

Support Center